Pediatric Dosing Principles
Why children are not simply small adults when it comes to medications — how age and weight affect dosing, why many drugs lack pediatric data, and how to dose safely.
Children Are Not Small Adults
For most of the history of medicine, children were treated as smaller versions of adults when it came to medications. Doses were estimated by halving or quartering adult doses, or by applying simple rules of thumb based on age or weight. We now know this approach was seriously flawed — and in some cases, dangerous.
Children's bodies process drugs fundamentally differently from adults. Their organs are developing. Their body composition changes dramatically across the first two decades of life. Their enzyme systems mature at different rates. A neonate (a baby less than four weeks old) metabolizes drugs in ways that are profoundly different from a six-year-old, who in turn differs from a teenager. Understanding these differences is the foundation of pediatric pharmacology.
How Age Affects Drug Processing
Drug processing — absorption, distribution, metabolism, and elimination — changes continuously throughout childhood.
Absorption: Newborns have lower stomach acid than adults, which affects the absorption of acid-dependent drugs. Gastric emptying time is also slower in infants, which can delay the time it takes for a drug to reach peak concentration. Skin absorption is proportionally higher in infants because their skin is thinner and their surface-area-to-body-weight ratio is much larger, making topical medications potentially more potent.
Distribution: Body composition shifts dramatically with age. Newborns are approximately 75–80% water by body weight, compared to about 60% in adults. This higher water content means that water-soluble drugs distribute into a larger volume relative to body weight, often requiring higher weight-adjusted doses to achieve the same concentration. Fat content is lower at birth, rises through infancy and childhood, then changes again in adolescence.
Metabolism: The liver enzymes that metabolize most drugs (the cytochrome P450Cytochrome P450 A superfamily of liver enzymes responsible for metabolizing approximately 75% of all drugs. Key isoforms include CYP3A4 (metabolizes ~50% of drugs), CYP2D6, CYP2C9, and CYP1A2. Drugs that inhibit or i
Elimination: The kidneys are the primary route of elimination for many drugs. Renal function at birth is only about 30–40% of adult capacity, maturing to adult levels by about 12–18 months of age. Premature infants have even lower kidney function. Drugs primarily cleared by the kidneys require dose adjustments in newborns and young infants.
Weight-Based Dosing
The most common method for calculating pediatric doses is weight-based dosing, expressed in milligrams per kilogram of body weight (mg/kg). For example, acetaminophen for children is typically dosed at 10–15 mg/kg every 4–6 hours.
This approach accounts for the most obvious source of variability — body size. However, weight-based dosing has limits. At the extremes (very young infants, obese adolescents), simple weight-based calculations can over- or under-dose. For this reason, pediatric dosing references often specify both a per-kilogram dose and a maximum dose (usually equivalent to the adult dose).
Always use a child's current weight in kilograms, not an estimated or remembered weight, when calculating medication doses.
Loading Doses in Pediatrics
A loading doseLoading Dose An initial higher dose of medication given to rapidly achieve therapeutic blood levels before transitioning to a lower maintenance dose. Loading doses are used for drugs with long half-lives that woul The condition where the rate of drug administration equals the rate of drug elimination, resulting in a stable average plasma concentration. Steady state is typically reached after 4-5 half-lives of c
In pediatrics, the loading dose calculation is based on volume of distributionVolume of Distribution A theoretical volume that relates the total amount of drug in the body to its plasma concentration. A large Vd indicates the drug distributes extensively into tissues, while a small Vd suggests the dr
clearanceClearanceThe volume of plasma from which a drug is completely removed per unit time, reflecting the body's efficiency at eliminating the drug. Clearance is primarily determined by liver metabolism and kidney e
-and-why-children-sometimes-need-more-frequent-doses">Clearance and Why Children Sometimes Need More Frequent Doses
Clearance is a measure of how efficiently the body removes a drug from circulation — essentially, the volume of blood "cleared" of the drug per unit time. Children often have higher weight-adjusted clearance rates than adults for many drugs, particularly those metabolized by the liver.
This has an important practical implication: for some drugs, children need either higher per-kilogram doses or more frequent dosing intervals than adults to maintain therapeutic levels. This counterintuitive fact surprises many parents and even some healthcare providers who assume children should always get less medication than adults.
As children approach adolescence and their enzyme systems mature to adult levels, their clearance rates decrease, and adult-style dosing becomes appropriate.
Volume of Distribution in Children
Volume of distribution (Vd) is a theoretical measure of how widely a drug distributes throughout the body. A large Vd means the drug distributes extensively into tissues; a small Vd means it stays mostly in the bloodstream.
In young children, the expanded extracellular fluid compartment (higher body water) increases the Vd for water-soluble drugs. This dilution effect means that to achieve the same plasma concentration as an adult, a child may need a higher weight-adjusted dose. As body composition normalizes through childhood, Vd approaches adult values.
The Off-Label Drug Problem in Pediatrics
A persistent challenge in pediatric pharmacology is that many drugs commonly used in children were never formally studied in pediatric populations before approval. They were tested in adults, approved for adults, and then used in children based on extrapolated dosing — a practice known as off-label useOff-Label Use The use of a drug for a purpose, population, or dosage not included in its FDA-approved labeling. Off-label prescribing is legal and common — an estimated 20% of all prescriptions are off-label — but
Studies have found that 50–75% of drugs used in hospitalized children are used off-label. This is not inherently wrong — off-label use is legal and sometimes medically appropriate — but it does mean that dosing data, safety profiles, and efficacyEfficacy The maximum therapeutic effect a drug can produce, regardless of the dose given. A drug with higher efficacy can achieve a greater maximum response than one with lower efficacy, even if the latter is
Regulatory initiatives such as the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) in the United States have required manufacturers to study their drugs in children in exchange for patent extensions. This has improved the evidence base, but gaps remain.
Age-Specific Considerations
Neonates (0–28 Days)
Neonates are the most pharmacologically vulnerable patients. Immature liver and kidney function, thin skin, different body composition, and developing blood-brain barrier all affect drug handling. Some drugs that are safe in older children are dangerous for neonates. Chloramphenicol, for example, causes "gray baby syndrome" in neonates because their immature livers cannot conjugate the drug adequately.
Infants and Toddlers (1 Month–2 Years)
During this period, liver enzymes mature rapidly. Some enzymes actually surpass adult activity levels, leading to faster metabolism and sometimes shorter drug half-lives than in adults. Dosing intervals may need to be shorter. Liquid formulations are standard; dose measurement accuracy is important — always use a calibrated dosing syringe, not a kitchen spoon.
School-Age Children and Adolescents
By school age, most pharmacokinetic parameters approach adult values, though full maturation continues through adolescence. Adolescents who are physically mature but not yet adults may be transitioned to adult dosing. For some drugs (particularly psychiatric medications), adolescent dosing requires careful individual assessment.
Practical Tips for Parents
Use calibrated measuring devices: A kitchen teaspoon holds 3–7 mL, not the standard 5 mL. Always use the oral dosing syringe that comes with liquid medications.
Dose by weight, not age: Age-based dosing on OTC medication boxes is a rough approximation. If your child's weight is known, use weight-based dosing when provided on the label or directed by your pharmacist.
Check the dose, then check it again: Weight-based dosing errors are a leading cause of pediatric medication mishaps. Double-checking the calculation is standard practice in pediatric units and should be at home too.
Ask for written instructions: If a provider prescribes medication for your child, ask for written dosing instructions that include the dose in milligrams and the volume in milliliters for your specific child's weight.
Tell providers the child's current weight: Dosing is only as accurate as the weight it is based on.
Key Takeaways
- Children are not small adults — age-dependent differences in absorption, distribution, metabolism, and elimination mean adult doses cannot simply be scaled down.
- Higher body water in young children increases the volume of distribution for water-soluble drugs, sometimes requiring higher weight-adjusted doses.
- Liver enzyme immaturity in neonates can dramatically slow drug metabolism; some enzymes are actually more active in toddlers than adults.
- Clearance is often higher in children per kilogram, meaning some drugs need more frequent dosing.
- Loading doses in pediatrics are based on volume of distribution and may be higher per kg than adult loading doses.
- Many drugs used in children are off-label; the evidence base has improved but gaps remain.
- Always use calibrated measuring devices and dose by current body weight in kilograms.